Literature DB >> 2066558

Flutamide-related fulminant hepatic failure.

J C Corkery, W Bihrle, J A McCaffrey, F F Whitcomb, C Levy, R Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2066558     DOI： 10.1097/00004836-199106000-00025

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN： 0192-0790            Impact factor:   3.062


× No keyword cloud information.
  4 in total

Review 1.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors:  M Pirmohamed; S Madden; B K Park
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

2.  Cholestatic hepatitis following flutamide.

Authors:  A S Rosman; C Frissora-Rodeo; A T Marshall; B P Reiter; F Paronetto
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

3.  Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis.

Authors:  C Cicognani; M Malavolti; A M Morselli-Labate; C Sama; L Barbara
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

Review 4.  [Toxic hepatitis and liver failure under therapy with flutamide].

Authors:  C Lübbert; M Wiese; R Haupt; B R Ruf
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.